PTC-话题@MedSci

#PTC#

16篇内容 | 1011人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1993458, encodeId=53b7199345893, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较, objectType=article, longId=723599, objectId=f956e235993f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f956e235993f, replyNumber=0, likeNumber=68, createdTime=2022-05-20, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f956e235993f, moduleTitle=Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f956e235993f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993457, encodeId=1100199345ea6, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=Ann Oncol：ECHELON-2研究更新数据表明，A+CHP较CHOP持续改善CD30+外周T细胞淋巴瘤(PTCL)患者的预后, objectType=article, longId=292661, objectId=f0b9292661bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0b9292661bc, replyNumber=0, likeNumber=66, createdTime=2022-10-24, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0b9292661bc, moduleTitle=Ann Oncol：ECHELON-2研究更新数据表明，A+CHP较CHOP持续改善CD30+外周T细胞淋巴瘤(PTCL)患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0b9292661bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993459, encodeId=f0cf1993459c1, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=【印记】中国冠脉介入之缘起：首例PTCA，拉开中国冠心病介入治疗序幕, objectType=article, longId=255767, objectId=3577255e675f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3577255e675f, replyNumber=0, likeNumber=67, createdTime=2022-06-14, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3577255e675f, moduleTitle=【印记】中国冠脉介入之缘起：首例PTCA，拉开中国冠心病介入治疗序幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3577255e675f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993456, encodeId=7fdf19934563e, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=Front Oncol：西达本胺（chidamide）治疗中国复发或难治性(R/R) 外周T细胞淋巴瘤（PTCL）的真实世界的疗效, objectType=article, longId=219960, objectId=f2d521996079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2d521996079, replyNumber=0, likeNumber=121, createdTime=2022-02-07, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2d521996079, moduleTitle=Front Oncol：西达本胺（chidamide）治疗中国复发或难治性(R/R) 外周T细胞淋巴瘤（PTCL）的真实世界的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2d521996079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993454, encodeId=ec5f199345443, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性, objectType=article, longId=214110, objectId=d47e2141105c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d47e2141105c, replyNumber=0, likeNumber=86, createdTime=2022-02-02, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d47e2141105c, moduleTitle=J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d47e2141105c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993452, encodeId=e05919934521e, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, objectType=article, longId=205090, objectId=009e20509087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009e20509087, replyNumber=0, likeNumber=69, createdTime=2021-10-31, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009e20509087, moduleTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009e20509087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993455, encodeId=204319934552b, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=科普贴：外周T细胞淋巴瘤（PTCL）, objectType=article, longId=215397, objectId=3c8321539ee2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c8321539ee2, replyNumber=0, likeNumber=148, createdTime=2021-12-05, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c8321539ee2, moduleTitle=科普贴：外周T细胞淋巴瘤（PTCL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c8321539ee2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993453, encodeId=a9e7199345390, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=Nano Today：PtCu合金纳米酶有望治疗帕金森病, objectType=article, longId=205414, objectId=fa8d2054140c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa8d2054140c, replyNumber=0, likeNumber=89, createdTime=2021-11-05, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa8d2054140c, moduleTitle=Nano Today：PtCu合金纳米酶有望治疗帕金森病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa8d2054140c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993451, encodeId=4b24199345119, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21, objectType=article, longId=185587, objectId=0f9018558e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f9018558e8f, replyNumber=0, likeNumber=101, createdTime=2020-05-22, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f9018558e8f, moduleTitle=Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f9018558e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993450, encodeId=93f71993450a1, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=PTC杜氏肌营养不良药物Translarna获NICE支持批准, objectType=article, longId=73922, objectId=09e8e392282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e8e392282, replyNumber=0, likeNumber=98, createdTime=2016-12-21, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e8e392282, moduleTitle=PTC杜氏肌营养不良药物Translarna获NICE支持批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09e8e392282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993449, encodeId=083b1993449e3, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=PTC杜氏营养肌不良症药物被拒, objectType=article, longId=64051, objectId=20bf640515d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20bf640515d, replyNumber=0, likeNumber=101, createdTime=2016-11-12, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20bf640515d, moduleTitle=PTC杜氏营养肌不良症药物被拒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20bf640515d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993448, encodeId=614b199344887, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=PTCOG 2014：质子重离子治疗肿瘤对话中外专家, objectType=article, longId=36443, objectId=f067364433f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f067364433f, replyNumber=0, likeNumber=62, createdTime=2014-08-08, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f067364433f, moduleTitle=PTCOG 2014：质子重离子治疗肿瘤对话中外专家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f067364433f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993447, encodeId=b8c1199344e15, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=JCO：标准化疗可改善部分复发或难治性PTCL患者结局, objectType=article, longId=28300, objectId=1eaf283001a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eaf283001a, replyNumber=0, likeNumber=67, createdTime=2014-11-03, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eaf283001a, moduleTitle=JCO：标准化疗可改善部分复发或难治性PTCL患者结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eaf283001a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993445, encodeId=ac1a1993445f2, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=JCO：香港研究者发现部分复发或难治性PTCL患者可经常规化疗取得良好结局, objectType=article, longId=17775, objectId=973f1e77539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=973f1e77539, replyNumber=0, likeNumber=69, createdTime=2013-11-28, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=973f1e77539, moduleTitle=JCO：香港研究者发现部分复发或难治性PTCL患者可经常规化疗取得良好结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=973f1e77539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993446, encodeId=8bb11993446d3, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, objectType=article, longId=19038, objectId=374b190383a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=374b190383a, replyNumber=0, likeNumber=88, createdTime=2013-08-11, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=374b190383a, moduleTitle=安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=374b190383a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993444, encodeId=a04f199344427, content=<a href='/topic/show?id=24fa14828b6' target=_blank style='color:#2F92EE;'>#PTC#</a>, objectTitle=巴西长达7年全国性队列研究：PTCA对比CABG, objectType=article, longId=5712, objectId=dd475e1258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd475e1258, replyNumber=0, likeNumber=65, createdTime=2012-11-25, rootId=0, userName=ms6279672939590805, userId=29702500197, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd475e1258, moduleTitle=巴西长达7年全国性队列研究：PTCA对比CABG, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd475e1258)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PTC

2020-05-29

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

Leukemia：自体或异体造血细胞移植治疗复发或难治性 PTCL-NOS 或 AITL生存结果的比较

2022-05-20

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

Ann Oncol：ECHELON-2研究更新数据表明，A+CHP较CHOP持续改善CD30+外周T细胞淋巴瘤(PTCL)患者的预后

2022-10-24

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

【印记】中国冠脉介入之缘起：首例PTCA，拉开中国冠心病介入治疗序幕

2022-06-14

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

Front Oncol：西达本胺（chidamide）治疗中国复发或难治性(R/R) 外周T细胞淋巴瘤（PTCL）的真实世界的疗效

2022-02-07

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

J Hematol Oncol：PD-1单抗---杰诺单抗注射液(geptanolimab）对外周T细胞淋巴瘤(PTCL) 的疗效与安全性

2022-02-02

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究

2021-10-31

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

科普贴：外周T细胞淋巴瘤（PTCL）

2021-12-05

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

Nano Today：PtCu合金纳米酶有望治疗帕金森病

2021-11-05

医者仁心 (审核中...)

前往app查看评论内容

#PTC#

Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21

2020-05-22

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

PTC杜氏肌营养不良药物Translarna获NICE支持批准

2016-12-21

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

PTC杜氏营养肌不良症药物被拒

2016-11-12

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

PTCOG 2014：质子重离子治疗肿瘤对话中外专家

2014-08-08

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

JCO：标准化疗可改善部分复发或难治性PTCL患者结局

2014-11-03

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

JCO：香港研究者发现部分复发或难治性PTCL患者可经常规化疗取得良好结局

2013-11-28

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

安慰剂效应——Ted Kaptchuk找到了“假”药中的真成分

2013-08-11

ms6279672939590805 (审核中...)

前往app查看评论内容

#PTC#

巴西长达7年全国性队列研究：PTCA对比CABG

2012-11-25

科室
- - 订阅+
  - 更多科室
工具
服务